Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Tofacitinib may effectively treat folliculitis decalvans.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib taken by mouth helps treat hair loss in children.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib, a hair regrowth treatment, may worsen acne.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

A woman with Fox-Fordyce disease had symptom relief using tretinoin cream.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Concurrent laser and isotretinoin treatment improves acne scars more than delayed treatment.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.